Blocknomi
Key Highlights Shares of Theriva Biologics (TOVX) surged 63% following the release of encouraging VIRAGE Phase 2b clinical trial results Combination therapy using VCN-01 with conventional chemotherapy demonstrated enhanced overall…
Related articles
-
Hyperliquid Price Soars as Founder Yan Rejects $100M Funding Offer
CryptoNewsZ Published 13.04.2026 09:47
-
Analyst Says Ethereum Just Confirmed A ‘Turtle Soup’, Here’s What It Means
NewsBTC Published 20.04.2026 07:00
-
Top US law firm admits AI hallucinations in legal filing
Crypto.News Published 22.04.2026 06:45
-
From Discovery to Trajectory: What This Means for Stabull Going Into 2026
Brave New Coin Published 19.04.2026 21:02
-
Your AI Chats Can Be Used Against You in Court—Law Firms Are Scrambling
Decrypt Published 16.04.2026 18:42
-
Bitcoin Set For Stronger Week, Eyes $88K On Stable Macro Backdrop: Analyst
NewsBTC Published 22.04.2026 14:00
-
TRON Integrates LI.FI Protocol, Unlocking Cross-Chain Access to Global Stablecoin Liquidity
Bitcoin.com Published 21.04.2026 17:00
-
Bitcoin Eyes $85K as Falling Volatility and ETF Inflows Fuel Bullish Momentum
BlockchainReporter Published 17.04.2026 17:50